Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) Study.
Jeon SY, Han HS, Bae WK, Park MR, Shim H, Lee SC, Go SI, Yun HJ, Im YJ, Song EK. Jeon SY, et al. Among authors: song ek. Cancer Res Treat. 2019 Jan;51(1):90-97. doi: 10.4143/crt.2017.577. Epub 2018 Feb 27. Cancer Res Treat. 2019. PMID: 29510613 Free PMC article. Clinical Trial.
The prognostic significance of tumor human papillomavirus status for patients with anal squamous cell carcinoma treated with combined chemoradiotherapy.
Yhim HY, Lee NR, Song EK, Kwak JY, Lee ST, Kim JH, Kim JS, Park HS, Chung IJ, Shim HJ, Hwang JE, Kim HR, Nam TK, Park MR, Shim H, Park HS, Kim HS, Yim CY. Yhim HY, et al. Among authors: song ek. Int J Cancer. 2011 Oct 1;129(7):1752-60. doi: 10.1002/ijc.25825. Epub 2011 Feb 26. Int J Cancer. 2011. PMID: 21128253
Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.
Kim HJ, Shin SW, Song EK, Lee NR, Kim JS, Ahn JS, Yun HJ, Cho YH, Park KU, Kim SY, Jang JS, Kim SW, Lee HW, Lee SR, Kim YS, Lee SN, Ko YH, Kim HJ, Kang JH. Kim HJ, et al. Among authors: song ek. Oncologist. 2015 Dec;20(12):1440-7. doi: 10.1634/theoncologist.2015-0128. Epub 2015 Oct 28. Oncologist. 2015. PMID: 26512046 Free PMC article. Clinical Trial.
Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilage invasion: A multicenter retrospective review.
Choi YS, Park SG, Song EK, Cho SH, Park MR, Park KU, Lee KH, Song IC, Lee HJ, Jo DY, Kim S, Yun HJ; Korean South West Oncology Group (KSWOG) Investigators. Choi YS, et al. Among authors: song ek, song ic. Head Neck. 2016 Aug;38(8):1271-7. doi: 10.1002/hed.24438. Epub 2016 Apr 4. Head Neck. 2016. PMID: 27043228
Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study.
Park K, Cho EK, Bello M, Ahn MJ, Thongprasert S, Song EK, Soldatenkova V, Depenbrock H, Puri T, Orlando M. Park K, et al. Among authors: song ek. Cancer Res Treat. 2017 Oct;49(4):937-946. doi: 10.4143/crt.2016.423. Epub 2017 Jan 6. Cancer Res Treat. 2017. PMID: 28111429 Free PMC article. Clinical Trial.
Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer.
Kim JW, Lee KW, Kim KP, Lee JH, Hong YS, Kim JE, Kim SY, Park SR, Nam BH, Cho SH, Chung IJ, Park YS, Oh HS, Lee MA, Kang HJ, Park YI, Song EK, Han HS, Lee KT, Shin DB, Kang JH, Zang DY, Kim JH, Kim TW. Kim JW, et al. Among authors: song ek. Oncologist. 2017 Mar;22(3):293-303. doi: 10.1634/theoncologist.2016-0166. Epub 2017 Feb 16. Oncologist. 2017. PMID: 28209749 Free PMC article.
Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).
Jung M, Ryu MH, Oh DY, Kang M, Zang DY, Hwang IG, Lee KW, Kim KH, Shim BY, Song EK, Sym SJ, Han HS, Park YL, Kim JS, Lee HW, Lee MH, Koo DH, Song HS, Lee N, Yang SH, Choi DR, Hong YS, Lee KE, Maeng CH, Baek JH, Kim S, Kim YH, Rha SY, Cho JY, Kang YK. Jung M, et al. Among authors: song ek, song hs. Gastric Cancer. 2018 Sep;21(5):819-830. doi: 10.1007/s10120-018-0806-1. Epub 2018 Feb 9. Gastric Cancer. 2018. PMID: 29427038 Clinical Trial.
340 results